Related Experiment Video
Updated: Jan 15, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Disseminated Talaromyces marneffei infection presenting as pulmonary cavitary nodules: a case report
Xiaoying Qin1, Jun Zou2, Zhiwen Jiang3
1Guangxi Medical University, Nanning, 530021, China.
Background:
Talaromycosis is an invasive fungal infection with high mortality in patients with advanced human immunodeficiency virus (HIV) disease in the tropical and subtropical regions of Asia. The lungs are the most commonly involved organ, and chest computed tomographic (CT) typically reveals diffuse pulmonary reticular and ground-glass changes. However, cavitary nodules are rare in HIV-positive patients, often leading to delay diagnosis.
Case Presentation:
A 46-year-old female with a 3-year history of untreated HIV infection was referred to our hospital due to recurrent fever lasting for 4 months. The chest CT showed a large nodular lesion with cavitary in the right lung, which was initially considered a neoplastic lesion at the referring hospital. A CT-guided percutaneous lung biopsy was performed, and fungal spores were found in lung pathology. Talaromyces marneffei was cultured from lung tissue and bone marrow at 4-day and 10-day post-sampling, respectively. The patient was diagnosed with disseminated talaromycosis. The patient received a two-week induction therapy with amphotericin B, resulting in a remarkable clinical response with substantial resolution of the cavitary pulmonary nodules. Following discharge, the patient continued antifungal therapy with itraconazole, and showed no evidence of disease recurrence during the 1-year follow-up period.
Conclusions:
This case highlights that pulmonary talaromycosis may present as cavitary nodular lesions, and further microbiological examination is indispensable for definitive diagnosis.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Other Pulmonary Disorders
